These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23098394)

  • 1. [The role of markers of inflammation in assessment of prognosis in patients with ST-elevation myocardial infarction combined with disturbances of carbohydrate metabolism].
    Karetnikova VN; Gruzdeva OV; Barbarash OL
    Kardiologiia; 2012; 52(8):20-6. PubMed ID: 23098394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Level of glycemia as a marker of prognosis in patients with myocardial infarction with ST segment elevation].
    Karetnikova VN; Belen'kova IuA; Zykov MV; Kashtalap VV; Gruzdeva OV; Barbarash OL
    Kardiologiia; 2012; 52(1):26-31. PubMed ID: 22304349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).
    Lim P; Moutereau S; Simon T; Gallet R; Probst V; Ferrieres J; Gueret P; Danchin N
    Am J Cardiol; 2013 Jan; 111(1):31-7. PubMed ID: 23062316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures.
    García-García C; Subirana I; Sala J; Bruguera J; Sanz G; Valle V; Arós F; Fiol M; Molina L; Serra J; Marrugat J; Elosua R
    Am J Cardiol; 2011 Oct; 108(8):1061-7. PubMed ID: 21791326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic usefulness of serial C-reactive protein measurements in ST-elevation acute myocardial infarction.
    Makrygiannis SS; Ampartzidou OS; Zairis MN; Patsourakos NG; Pitsavos C; Tousoulis D; Prekates AA; Foussas SG; Cokkinos DV
    Am J Cardiol; 2013 Jan; 111(1):26-30. PubMed ID: 23040593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormal glucose tolerance and long-term prognosis in patients with acute myocardial infarction].
    David LA; Grosu AA
    Kardiologiia; 2013; 53(9):15-20. PubMed ID: 24090381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.
    Canale ML; Stroppa S; Caravelli P; Petronio AS; Mariotti R; Mariani M; Balbarini A; Barsotti A
    Coron Artery Dis; 2006 Dec; 17(8):693-8. PubMed ID: 17119378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
    Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multifocal atherosclerosis as a factor of unfavorable prognosis in patients with ST elevation myocardial infarction and type 2 diabetes mellitus].
    Karetnikova VN; Belen'kova IuA; Zykov MV; Kashtalap IA; Shibanova IA; Barbarash OL
    Kardiologiia; 2013; 53(4):12-8. PubMed ID: 23952946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent myocardial infarction after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Kikkert WJ; Hoebers LP; Damman P; Lieve KV; Claessen BE; Vis MM; Baan J; Koch KT; de Winter RJ; Piek JJ; Tijssen JG; Henriques JP
    Am J Cardiol; 2014 Jan; 113(2):229-35. PubMed ID: 24188893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of admission high-density lipoprotein cholesterol level and in-hospital mortality in patients with acute non-ST segment elevation myocardial infarction (from the National Cardiovascular Data Registry).
    Acharjee S; Roe MT; Amsterdam EA; Holmes DN; Boden WE
    Am J Cardiol; 2013 Oct; 112(8):1057-62. PubMed ID: 23891245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value of various markers of inflammation in ST-elevation myocardial infarction].
    Barbarash OL; Zykov MV; Kashtalap VV; Osokina AV; Berns SA; Karetnikova VN
    Kardiologiia; 2011; 51(3):24-30. PubMed ID: 21627609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).
    James SK; Lindahl B; Timmer JR; Ottervanger JP; Siegbahn A; Stridsberg M; Armstrong P; Califf R; Wallentin L; Simoons ML
    Am J Cardiol; 2006 Jan; 97(2):167-72. PubMed ID: 16442356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST-segment deviation on the admission electrocardiogram, treatment strategy, and outcome in non-ST-elevation acute coronary syndromes A substudy of the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Trial.
    Windhausen F; Hirsch A; Tijssen JG; Cornel JH; Verheugt FW; Klees MI; de Winter RJ;
    J Electrocardiol; 2007; 40(5):408-15. PubMed ID: 17604045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
    Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
    J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Jensen LO; Maeng M; Thayssen P; Tilsted HH; Terkelsen CJ; Kaltoft A; Lassen JF; Hansen KN; Ravkilde J; Christiansen EH; Madsen M; Sørensen HT; Thuesen L
    Am J Cardiol; 2012 Mar; 109(5):629-35. PubMed ID: 22152969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of inflammatory markers between diabetic and nondiabetic ST segment elevation myocardial infarction.
    Heo JM; Park JH; Kim JH; You SH; Kim JS; Ahn CM; Hong SJ; Shin KH; Lim DS
    J Cardiol; 2012 Sep; 60(3):204-9. PubMed ID: 22658696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction.
    Sawant AC; Adhikari P; Narra SR; Srivatsa SS; Mills PK; Srivatsa SS
    Cardiol J; 2014; 21(5):500-8. PubMed ID: 24142685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.